Midwest Transplant Network
MTN Publications about A2/A2B to B and O Transplantation 1987 – 2013
…Our legacy toward making it part of the national renal allocation system
1.
Transplantation of blood group A2 cadaveric kidneys into O and B recipients.
American Nephrology Nurses Association Journal 1987, 14:395-6.
2.
Successful transplantation of blood group A2 kidneys into non-A recipients.
Transplantation 1988, 45:316-19.
3.
Current experience with renal transplantation across the ABO barrier. The American Journal of Surgery 1992,
164:541-5.
4.
Transplantation of blood group A2 donor kidneys across the ABO barrier. Visuals of the Clinical
Histocompatiblity Workshop, Cancun Invitational 1992, Terasaki, P., Ed. 65-6.
5.
Current experience with renal transplantation across the ABO blood group barrier. Transplantation
Proceedings 1992, 24:2527-29.
6.
Renal transplantation across the ABO barrier: The Midwest Organ Bank experience. Clinical Laboratory
Science 1993, 6:77-9.
7.
Stratification and successful transplantation of patients awaiting ABO-incompatible (A2 into B and O)
transplantation by A-isoagglutinin-titer phenogroup. Trans. Proc. 1996, 28:221-23.
8.
Ten-year experience in transplantation of A2 kidneys into B and O recipients.
Transplantation 1998, 65:256-60.
9.
ABO-mismatched renal transplantation in children: A report of the North American Pediatric Renal
Transplant Cooperative Study (NAPRTCS) and the Midwest Organ Bank (MOB).
Pediatric Transplantation
1998, 2:26-9.
10. Transplantation rate of the blood group B waiting list is increased by using A2 and A2B kidneys.
Transplantation 1998, 66:1714-17.
11. Increased access to transplantation for blood group B cadaveric waiting list candidates by using A 2
kidneys:Time for a new national system? Amer.Journal of Transplantation 2002, 2:94-9.
12. Proposal for a national voluntary variance to transplant A2 and A2B organs into blood group B recipients
(written by MTN). UNOS Policy Proposals 2001, 18.
13. ABO blood group influences a candidate’s likelihood of receiving an HLA zero antigen mismatch kidney.
Clinical Transplantation 18:55-60, 2004.
14. Improving access to kidney transplantation without decreasing graft survival: Long-term outcomes of blood
group A2/A2B deceased donor kidneys in B recipients. Transplantation 80:73-78, 2005.
15. Transplantation of A2 and A2B kidneys from deceased donors into B waiting list candidates increases their
transplantation rate. IN: Clinical Transplants 2004, Cecka JM, Terasaki, PI (eds.) Los Angeles, CA. UCLA
Immunogenetics Center, 2005.
16. Long-term survival of kidneys transplanted from live A2 donors to O and B recipients. American Journal of
Transplantation 2007;7:1181-84.
17. Implications of ABO error rates in proficiency testing for solid organ transplantation. Transplantation (Forum
Article) 82 (6):733-736, 2006 (contains data on A subgroup discrepancy rate)
18. The purpose and clinical applications of anti-A titers. College of American Pathologists, Participant summary,
HL-C survey, 2008.
19. Double verification of A subgrouping for organ donors: how much could it increase patient safety? American
Journal of Transplantation 2010 (abstract/poster at American Transplant Congress, San Diego).
20. When will real benefits be realized to minority candidates with A2 to B transplantation. Invited Analysis &
Commentary. Transplantation,89:1310-11, 2010.
21. Blood group A isoagglutinins in A2 to O simultaneous liver/kidney transplantation may not influence kidney
function. American Journal of Transplantation 2011;1527-30.
22. On June 24, 2013, UNOS Board of Directors made the A2/A2B → B allocation system
officially a part of the new kidney allocation algorithm that will be implemented in the
United States in 2014. The above papers we published are largely what UNOS used to
develop this new national allocation system.